2018.02.15 update

Daiwa House Industry announced its plan to transfer part of CYBERDYNE share and to hold the remaining share as a stable shareholder

Daiwa House Industry Co., Ltd. (“Daiwa House”), a major shareholder of CYBERDYNE, INC. (the “Company”) transferred 7,690,000 common shares that were part of the Company’s shares held by Daiwa House on February 15, 2018. The reason for the transfer by Daiwa House and its policy on the remaining 30,000,000 common shares of the Company are stated below.

On December 17, 2017, the Company obtained marketing clearance from the U.S. Food and Drug Association for HAL for Medical Use Lower Limb Type. This transfer of the shares was proposed by the Company, so that it could further promote the development of its business in the U.S., and expand the shareholder base to those with whom the Company could constructively discuss on business in North America.

Daiwa House Industry will continue to hold the Company shares as a stable shareholder in order to support the strategic development of the Company and to continue the relationship as a business partner.

Reference: News release by Daiwa House Industries (only available in Japanese)